Global Chronic Lower Back Pain Market
Healthcare Services

Chronic Lower Back Pain Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Chronic Lower Back Pain Market?

The chronic lower back pain market is predicted to expand due to a rise in the occurrence of nerve instances. Nerve instances are characterized by the display of courage, bravery, or resilience in adverse or challenging situations. Central sensitization, which basically refers to the heightened sensitivity of the nervous system, may result from persistent stress and pain, leading to intense pain perception, even without any actual physical injury. For instance, Nature, a reputable science journal based in the UK, reported in July 2023 that the prevalence of peripheral neuropathy, related to nerve damage, was documented at 28.4% in adults aged 40 and above with diabetes, and 11.8% in those without diabetes. Thus, the rise in nerve instances frequency is fueling the growth of the chronic lower back pain market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp

#How Will the CAGR of the Chronic Lower Back Pain Market Influence Its Overall Growth by 2034?

Over the years, the market size for chronic lower back pain has seen a consistent growth. This is anticipated to increase from $7.72 billion in 2024 to $8.08 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.6%. Factors contributing to this growth seen previously include an increase in sedentary lifestyles, risks associated with manual labor and occupations, advancements in medical diagnosis, the evolution of pain management strategies, and epidemiological research.

The market size for chronic lower back pain is projected to witness robust growth in the upcoming years, escalating to $9.99 billion in 2029 with a compound annual growth rate (CAGR) of 5.5%. Factors such as the increase in non-pharmacological interventions, preventative healthcare movements, emphasis on comprehensive treatments, advancements in regenerative medicine, and trends in the aging population contribute to the growth during the forecast period. The period also shows a trend of focusing on non-pharmacological interventions, a shift in pain management techniques, increased awareness and education in healthcare, the rise of telemedicine and remote monitoring, and the incorporation of regenerative medicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9946

What New Market Trends Are Reshaping theChronic Lower Back Pain Market and Its Opportunities?

Key players within the chronic lower back pain market are concentrating their efforts on creating novel medications for their consumers in order to maintain their market standing. The introduction of these new drugs has the potential to enhance therapeutic results for patients suffering from a range of conditions. For instance, in July 2022, Amneal Pharmaceuticals, a pharmaceutical company based in the USA, introduced LYVISPAH, a baclofen oral granule (5, 10, and 20 mg) that received U.S. FDA approval for the management of spasticity linked with multiple sclerosis and other spinal cord disorders. LYVISPAH addresses and mitigates flexor spasms, related pain, clones, and muscle rigidity. It offers a flexible, personalized dosage in single-dose granule packets with doses of 5 mg, 10 mg, and 20 mg and it is bioequivalent to oral baclofen tablets. LYVISPAH could also be beneficial to patients with spinal cord injuries and other spinal cord diseases.

Who Are the Leading Market Players Fueling Growth in the Chronic Lower Back Pain Market Trend?

Major companies operating in the chronic lower back pain market include Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy’s Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

How is the Global Chronic Lower Back Pain Market Segemented?

The chronic lower back pain market covered in this report is segmented –

1) By Type Of Pain: Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain

2) By Diagnosis: Clinical History, Physical Examination, Imaging Guidelines, Assessment Of Pain

3) By End-User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Diskogenic Pain: Herniated Disc, Degenerative Disc Disease, Disc Bulge, Lumbar Spinal Stenosis

2) By Lumbar Spinal Stenosis: Central Stenosis, Lateral Stenosis

3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction, Inflammatory Conditions

4) By Facet-Joint Pain: Facet Joint Syndrome, Osteoarthritis Of The Facet Joints

5) By Radicular Pain: Sciatica, Nerve Root Compression

6) By Muscular Pain: Muscle Strain, Muscle Spasm

7) By Other Types of Pain: Myofascial Pain Syndrome, Spondylolisthesis, Osteoporosis-Related Pain

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9946&type=smpGlobal Chronic Lower Back Pain Market, Global Chronic Lower Back Pain Market Report, Global Chronic Lower Back Pain Market Trends, Global Chronic Lower Back Pain Market Size

Browse Through More Reports Similar to the Gobal Chronic Lower Back Pain Maret 2025, By The Business Research Company:

Product Engineering Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/product-engineering-services-global-market-report

Professional Services Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/professional-services-market

Ventricular Assist Device Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: